In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- McCraken Finishes Strong in Five-Furlong Move
- Capps' Death is Big Loss to Louisville Equine Program
- Romans Mulling Rider Options for J Boys Echo
- Brisk Activity Bodes Well for OBS Spring Sale
- Goldikova, Espinoza Among Hall of Fame Inductees
- Nichols Canyon Connections Pointing for Iroquois Bonus
- Albarado Fractures Lower Leg, Off J Boys Echo in Derby
- Santa Anita Cancels April 27 Racing
- Spending Time With New Trainer Kent Sweezey
- OBS Hips to Watch Include Tapwrit's Half Brother